The Canadian guidelines 9 recommended the use of erythromycin for treating pregnant women suffering Lymphogranuloma venereum LGV; however, our experts prioritised azithromycin to promote adherence level of evidence: very low.
La “Guía canadiense” 9 recomienda el uso de eritromicina para el tratamiento de la mujer gestante LGV.